Solvay reaches nearly $393 million PFAS settlement with New Jersey

BRUSSELS (Reuters) -The U.S. branch of Belgian chemicals company Solvay has struck a nearly $393-million deal with the New Jersey Department of Environmental Protection (NJDEP) to settle some claims linked to drinking water pollution caused by one of its plants, Solvay announced on Wednesday. The funds will be used to test for, filter and clean…

Read More

Nursing home owners stole $83 million while neglecting residents, NY lawsuit says

By Brendan Pierson (Reuters) -New York’s attorney general on Wednesday accused nursing home operator Centers Health Care and its owners of stealing $83 million in government funds while understaffing its facilities, resulting in widespread neglect, illness and death among residents. In a lawsuit filed in state court in Manhattan, Attorney General Letitia James sought to…

Read More

US announces charges in $2.5 billion healthcare fraud takedown

By Sarah N. Lynch WASHINGTON (Reuters) -The U.S. Justice Department on Wednesday announced federal and local criminal charges targeting 78 defendants across 16 states as part of a law enforcement action involving $2.5 billion in alleged healthcare fraud schemes targeting elderly and disabled people, HIV patients and even pregnant women. The cases range from allegations…

Read More

Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs

(This June 27 story has been corrected to say that Versanis drug was licensed from Novartis in paragraph 19) By Deena Beasley SAN DIEGO (Reuters) – New data on weight loss drugs that could compete with Novo Nordisk’s Wegovy are raising expectations there will soon be more options, and possibly lower prices, in an estimated…

Read More

One in seven Britons faced hunger in 2022, says food bank charity

By James Davey LONDON (Reuters) – One in seven people in the United Kingdom faced hunger last year because they did not have enough money, according to a report published on Wednesday by food bank charity the Trussell Trust. It said this equates to 11.3 million people, more than double the population of Scotland, and…

Read More

US FDA declines to approve Regeneron’s higher-dose Eylea, shares tumble

By Khushi Mandowara (Reuters) – U.S. health regulators on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ drug Eylea for treatment of a disease that is leading cause of blindness among the elderly, the company said as shares fell on the setback to its effort to defend the blockbuster treatment against a fast-gaining…

Read More

New scheme aims to get vaccines to outbreaks faster – Gavi

By Jennifer Rigby LONDON (Reuters) – Three global health bodies are teaming up to investigate stockpiling experimental vaccines for rare infectious diseases so the shots can be tested more quickly when outbreaks happen, a top official from vaccine alliance Gavi told Reuters. The initiative will be led by Gavi, the World Health Organization (WHO) and…

Read More